According to Insight Life's announcement, the four medical device registration applications for anti-epileptic drug concentration measurement kits declared by the holding subsidiary Shanghai Maishi Biotechnology Co., Ltd. were recently accepted by the Shanghai Drug Administration. Currently, the registration application is in the acceptance stage, and technical review, administrative approval, and approval procedures are still required.

According to Insight Life's announcement, the four medical device registration applications for anti-epileptic drug concentration measurement kits declared by the holding subsidiary Shanghai Maishi Biotechnology Co., Ltd. were recently accepted by the Shanghai Drug Administration. Currently, the registration application is in the acceptance stage, and technical review, administrative approval, and approval procedures are still required.